Maravai LifeSciences Ownership | Who Owns Maravai LifeSciences?
Maravai LifeSciences Ownership Summary
Maravai LifeSciences is owned by 96.40% institutional investors, 1.20% insiders, and 2.40% retail investors. Gtcr is the largest institutional shareholder, holding 14.23% of MRVI shares. Canada Life US Small-Mid Cap Growth A is the top mutual fund, with 3.22% of its assets in Maravai LifeSciences shares.
MRVI Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Maravai LifeSciences | 96.40% | 1.20% | 2.40% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Gtcr | 20.15M | 14.23% | $109.82M |
Vanguard group | 11.82M | 8.35% | $64.43M |
12 west capital management lp | 11.59M | 8.19% | $63.17M |
Blackrock | 9.73M | 7.35% | $69.66M |
Blackrock funding, inc. /de | 9.78M | 6.91% | $53.29M |
Braidwell lp | 8.35M | 5.90% | $45.53M |
Mackenzie financial | 6.18M | 4.37% | $31.41M |
Alyeska investment group | 5.33M | 3.76% | $29.05M |
Massachusetts financial services co /ma/ | 4.66M | 3.29% | $25.42M |
Jpmorgan chase | 4.25M | 3.00% | $23.17M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Gtcr | 20.15M | 10.56% | $109.82M |
12 west capital management lp | 11.59M | 6.62% | $63.17M |
Braidwell lp | 8.35M | 1.35% | $45.53M |
Penderfund capital management | 580.30K | 0.98% | $4.55M |
Alpine peaks capital, lp | 204.00K | 0.91% | $1.11M |
Pier capital | 1.13M | 0.88% | $6.15M |
Sivik global healthcare | 140.00K | 0.40% | $763.00K |
Point72 (difc) | 1.56M | 0.31% | $8.48M |
Centerbook partners lp | 811.93K | 0.26% | $4.42M |
Parkman healthcare partners | 350.00K | 0.25% | $1.91M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 9.73M | 0.00% | 3.31M |
Alyeska investment group | 5.33M | 0.11% | 3.16M |
Marshall wace, llp | 2.78M | 0.02% | 2.76M |
Ubs group | 1.95M | 0.00% | 1.72M |
Massachusetts financial services co /ma/ | 4.66M | 0.01% | 1.06M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Point72 europe (london) llp | - | - | -2.47M |
12 west capital management lp | 11.59M | 6.62% | -2.42M |
Millennium management | 1.91M | 0.01% | -2.42M |
First trust advisors lp | - | - | -2.40M |
Portolan capital management | - | - | -1.79M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Centerbook partners lp | 811.93K | 0.26% | 811.93K | $4.42M |
Penderfund capital management | 580.30K | 0.98% | 580.30K | $4.55M |
Parkman healthcare partners | 350.00K | 0.25% | 350.00K | $1.91M |
Wealthfront advisers | 191.90K | 0.06% | 191.90K | $19.03M |
Hrt financial lp | 153.68K | 0.00% | 153.68K | $837.00K |
Sold Out
Holder | Change |
---|---|
Sjs investment consulting | -2.00 |
Jfs wealth advisors | -5.00 |
Assetmark | -21.00 |
Financial network wealth advisors | -29.00 |
Systm wealth solutions | -44.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 172 | -21.82% | 136,455,890 | -5.23% | 96 | 0.93% | 81 | -27.68% | 59 | -13.24% |
Sep 30, 2024 | 220 | 6.80% | 143,991,590 | -2.29% | 101 | 0.82% | 113 | - | 68 | -1.45% |
Jun 30, 2024 | 206 | -3.74% | 147,373,447 | 8.71% | 111 | 1.06% | 113 | 1.80% | 69 | -2.82% |
Mar 31, 2024 | 214 | -4.89% | 135,569,995 | 0.60% | 102 | 0.98% | 111 | -18.98% | 71 | 12.70% |
Dec 31, 2023 | 225 | 8.70% | 134,766,352 | 0.18% | 102 | 0.98% | 137 | 10.48% | 63 | 12.50% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Canada Life US Small-Mid Cap Growth A | 4.57M | 3.22% | - |
Canada Life US Small-Mid Cap Growth F | 4.57M | 3.18% | - |
Vanguard US Total Market Shares ETF | 3.94M | 2.74% | 547.00K |
Vanguard Total Stock Mkt Idx Inv | 3.78M | 2.66% | - |
Vanguard Small Cap Index | 3.08M | 2.17% | 2.52K |
iShares Russell 2000 ETF | 2.97M | 2.07% | -25.74K |
Columbia Acorn Inst | 2.26M | 1.57% | - |
Glenmede Small Cap Equity Adv | 2.03M | 1.43% | -14.85K |
Glenmede Small Cap Equity | 2.03M | 1.43% | -14.85K |
MFS New Discovery Value I | 2.01M | 1.42% | -28.80K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 31, 2025 | ORESHACK KURT | General Counsel | Sell | $125.75K |
Nov 12, 2024 | DeFord John A | - | Buy | $100.63K |
Nov 11, 2024 | HULL CARL | See Remarks | Buy | $987.00K |
May 28, 2024 | GTCR INVESTMENT XI LLC | Sell | $97.57M | |
Nov 25, 2020 | HULL CARL | Chief Executive Officer | Buy | $942.90K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 1 |
2024 Q4 | 2 | - |
2024 Q3 | - | - |
2024 Q2 | - | 1 |
2024 Q1 | - | - |
MRVI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools